The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a ...
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians. Fresenius Kabi has announced the launch of Glycopyrrolate Injection, USP 0.6mg per 3mL in the Simplist ® ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
In October 2025, Samsung Bioepis announced that the company will assume full commercial responsibility for BYOOVIZ in Europe upon full transition of Biogen’s commercialization rights back to Samsung ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
Fresenius Kabi has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist ...
The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Disposable Syringes Market Size, Trends & Analysis, By Product Type, By Application, By End Use, And By Region, Global Forecast To 2028" report has been ...
Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ (ranibizumab) pre-filled syringe (PFS) PFS presentation to become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback